Since the awards programme was established in 2018, we have received a high number of high-quality submissions, and progressed with new grants every year. We are proud to share the winners of past research grants below. 

Any queries should be directed to [email protected]

2023 winners

Pearse A. Keane, United Kingdom: €120,994
Predicting progressive macular atrophy in patients undergoing anti-VEGF therapy for neovascular age-related macular degeneration using multi-modal imaging, genetics, and artificial intelligence

João Pedro Marques, Portugal: €299,879
“EYS on” gene editing for Retinitis Pigmentosa 25

Enrico Borrelli, Italy: €263,806
The role of mitochondria in geographic atrophy progression in age-related macular degeneration

 

2022 winners

Suzanne Yzer, The Netherlands: €186,091
Risk of posterior staphyloma in highly myopic Europeans: from epidemiology to anatomy and back

Claudia Farinha, Portugal: €294,704
Diet, lifestyle, systemic medication and genetics: can the risk for AMD be modulated? (AMD_LifeGene)

 

2021 winners

Robert P. Finger, Germany: €293,350
Microbiome, metabolome and complement activation in age-related macular degeneration at the University Hospital Bonn 

Dominik Fischer, UK: €287,359
REGENT (RETiNal GENE ThERapy immuNE REsponNsE) at Oxford University Hospitals NHS Foundation Trust

 

2020 winners

Rufino Martins da Silva, Portugal: €223,981,59 
Metabolomics: An Integrative Tool for Investigating the Pathogenesis of Age-related Macular Degeneration at AIBILI – Association for Innovation and Biomedical Research on Light and Image

Gian Marco Tosi, Italy: €190,752.50
The C-type lectin receptor CD93 as a new target in retinal vascular diseases at the University of Siena

 

2019 winners

Camiel Boon, The Netherlands: €201,233
Juvenile X-linked retinoschisis: assessing the clinical and genetic spectrum in preparation for therapy

Roy Schwartz, UK: €262,112
Deep learning, large datasets, genome-wide analysis and histological correlates to determine the role of reticular pseudodrusen in the progression of age-related macular degeneration